|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
DeSantis CE, Fedewa SA, Goding Sauer A,
Kramer JL, Smith RA and Jemal A: Breast cancer statistics, 2015:
Convergence of incidence rates between black and white women. CA
Cancer J Clin. 66:31–42. 2016. View Article : Google Scholar
|
|
5
|
Muñoz-Díaz MM, Fernández-Aceñero MJ,
Salvadores P and Schneider J: Utility of a simplified molecular
classification of tumors for predicting survival of patients with
invasive ductal breast carcinoma. Anticancer Res. 29:4727–4730.
2009.PubMed/NCBI
|
|
6
|
Chen Z, Yang J, Li S, Lv M, Shen Y, Wang
B, Li P, Yi M, Zhao X, Zhang L, et al: Invasive lobular carcinoma
of the breast: A special histological type compared with invasive
ductal carcinoma. PLoS One. 12:e01823972017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Roulet M, Ruggiero F, Karsenty G and
LeGuellec D: A comprehensive study of the spatial and temporal
expression of the col5a1 gene in mouse embryos: A clue for
understanding collagen V function in developing connective tissues.
Cell Tissue Res. 327:323–332. 2007. View Article : Google Scholar
|
|
8
|
Fichard A, Tillet E, Delacoux F, Garrone R
and Ruggiero F: Human recombinant alpha1(V) collagen chain.
Homotrimeric assembly and subsequent processing. J Biol Chem.
272:30083–30087. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wenstrup RJ, Florer JB, Brunskill EW, Bell
SM, Chervoneva I and Birk DE: Type V collagen controls the
initiation of collagen fibril assembly. J Biol Chem.
279:53331–53337. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Borradaile NM and Pickering JG: Polyploidy
impairs human aortic endothelial cell function and is prevented by
nicotinamide phosphoribosyltransferase. Am J Physiol Cell Physiol.
298:C66–C74. 2010. View Article : Google Scholar
|
|
11
|
Suresh A, Vannan M, Kumaran D, Gümüs ZH,
Sivadas P, Murugaian EE, Kekatpure V, Iyer S, Thangaraj K and
Kuriakose MA: Resistance/response molecular signature for oral
tongue squamous cell carcinoma. Dis Markers. 32:51–64. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cheon DJ, Tong Y, Sim MS, Dering J, Berel
D, Cui X, Lester J, Beach JA, Tighiouart M, Walts AE, et al: A
collagen-remodeling gene signature regulated by TGF-β signaling is
associated with metastasis and poor survival in serous ovarian
cancer. Clin Cancer Res. 20:711–723. 2014. View Article : Google Scholar
|
|
13
|
Sun H: Identification of key genes
associated with gastric cancer based on DNA microarray data. Oncol
Lett. 11:525–530. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qiu J, Zhang W, Xia Q, Liu F, Li L, Zhao
S, Gao X, Zang C, Ge R and Sun Y: RNA sequencing identifies crucial
genes in papillary thyroid carcinoma (PTC) progression. Exp Mol
Pathol. 100:151–159. 2016. View Article : Google Scholar
|
|
15
|
Chai F, Liang Y, Zhang F, Wang M, Zhong L
and Jiang J: Systematically identify key genes in inflammatory and
noninflammatory breast cancer. Gene. 575:600–614. 2016. View Article : Google Scholar
|
|
16
|
Huang Y, Tao Y, Li X, Chang S, Jiang B, Li
F and Wang ZM: Bioinformatics analysis of key genes and latent
pathway interactions based on the anaplastic thyroid carcinoma gene
expression profile. Oncol Lett. 13:167–176. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kahai S, Vary CP, Gao Y and Seth A:
Collagen, type V, alpha1 (COL5A1) is regulated by TGF-beta in
osteoblasts. Matrix Biol. 23:445–455. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lo PK, Zhang Y, Yao Y, Wolfson B, Yu J,
Han SY, Duru N and Zhou Q: Tumor-associated myoepithelial cells
promote the invasive progression of ductal carcinomain situthrough
activation of TGFβ signaling. J Biol Chem. 292:11466–11484. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou D, Zhang L, Sun W, Guan W, Lin Q, Ren
W, Zhang J and Xu G: Cytidine monophosphate kinase is inhibited by
the TGF-β signalling pathway through the upregulation of
miR-130b-3p in human epithelial ovarian cancer. Cell Signal.
35:197–207. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang X, Gui L, Zhang Y, Zhang J, Shi J and
Xu G: Cystatin B is a progression marker of human epithelial
ovarian tumors mediated by the TGF-β signaling pathway. Int J
Oncol. 44:1099–1106. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhu Y, Guo M, Zhang L, Xu T, Wang L and Xu
G: Biomarker triplet NAMPT/VEGF/HER2 as a de novo detection panel
for the diagnosis and prognosis of human breast cancer. Oncol Rep.
35:454–462. 2016. View Article : Google Scholar
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
23
|
Finak G, Bertos N, Pepin F, Sadekova S,
Souleimanova M, Zhao H, Chen H, Omeroglu G, Meterissian S, Omeroglu
A, et al: Stromal gene expression predicts clinical outcome in
breast cancer. Nat Med. 14:518–527. 2008. View Article : Google Scholar
|
|
24
|
Ma XJ, Dahiya S, Richardson E, Erlander M
and Sgroi DC: Gene expression profiling of the tumor
microenvironment during breast cancer progression. Breast Cancer
Res. 11:R72009. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Radvanyi L, Singh-Sandhu D, Gallichan S,
Lovitt C, Pedyczak A, Mallo G, Gish K, Kwok K, Hanna W, Zubovits J,
et al: The gene associated with trichorhinophalangeal syndrome in
humans is overexpressed in breast cancer. Proc Natl Acad Sci USA.
102:11005–11010. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao H, Langerød A, Ji Y, Nowels KW,
Nesland JM, Tibshirani R, Bukholm IK, Kåresen R, Botstein D,
Børresen-Dale AL, et al: Different gene expression patterns in
invasive lobular and ductal carcinomas of the breast. Mol Biol
Cell. 15:2523–2536. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Curtis C, Shah SP, Chin SF, Turashvili G,
Rueda OM, Dunning MJ, Speed D, Lynch AG, Samarajiwa S, Yuan Y, et
al METABRIC Group: The genomic and transcriptomic architecture of
2,000 breast tumours reveals novel subgroups. Nature. 486:346–352.
2012.PubMed/NCBI
|
|
28
|
Györffy B, Lanczky A, Eklund AC, Denkert
C, Budczies J, Li Q and Szallasi Z: An online survival analysis
tool to rapidly assess the effect of 22,277 genes on breast cancer
prognosis using microarray data of 1,809 patients. Breast Cancer
Res Treat. 123:725–731. 2010. View Article : Google Scholar
|
|
29
|
Moore-Smith L and Pasche B: TGFBR1
signaling and breast cancer. J Mammary Gland Biol Neoplasia.
16:89–95. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mienaltowski MJ and Birk DE: Structure,
physiology, and biochemistry of collagens. Adv Exp Med Biol.
802:5–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kliese N, Gobrecht P, Pachow D, Andrae N,
Wilisch-Neumann A, Kirches E, Riek-Burchardt M, Angenstein F,
Reifenberger G, Riemenschneider MJ, et al: miRNA-145 is
downregulated in atypical and anaplastic meningiomas and negatively
regulates motility and proliferation of meningioma cells. Oncogene.
32:4712–4720. 2013. View Article : Google Scholar
|
|
32
|
Ewald JA, Downs TM, Cetnar JP and Ricke
WA: Expression microarray meta-analysis identifies genes associated
with Ras/MAPK and related pathways in progression of
muscle-invasive bladder transition cell carcinoma. PLoS One.
8:e554142013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hammoda GE, El-Hefnawy SM, Abdou AG and
Abdallah RA: Human epidermal growth factor receptor-3 mRNA
expression as a prognostic marker for invasive duct carcinoma not
otherwise specified. J Clin Diagn Res. 11:XC01–XC05.
2017.PubMed/NCBI
|
|
34
|
Engels CC, Fontein DB, Kuppen PJ, de
Kruijf EM, Smit VT, Nortier JW, Liefers GJ, van de Velde CJ and
Bastiaannet E: Immunological subtypes in breast cancer are
prognostic for invasive ductal but not for invasive lobular breast
carcinoma. Br J Cancer. 111:532–538. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kim SH, Hwang KA and Choi KC: Treatment
with kaempferol suppresses breast cancer cell growth caused by
estrogen and triclosan in cellular and xenograft breast cancer
models. J Nutr Biochem. 28:70–82. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Barcus CE, Keely PJ, Eliceiri KW and
Schuler LA: Prolactin signaling through focal adhesion complexes is
amplified by stiff extracellular matrices in breast cancer cells.
Oncotarget. 7:48093–48106. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ramos EA, Silva CT, Manica GC, Pereira IT,
Klassen LM, Ribeiro EM, Cavalli IJ, Braun-Prado K, Lima RS, Urban
CA, et al: Worse prognosis in breast cancer patients can be
predicted by immunohistochemical analysis of positive MMP-2 and
negative estrogen and progesterone receptors. Rev Assoc Med Bras
(1992). 62:774–781. 2016. View Article : Google Scholar
|
|
38
|
Sharangpani GM, Joshi AS, Porter K,
Deshpande AS, Keyhani S, Naik GA, Gholap AS and Barsky SH:
Semi-automated imaging system to quantitate estrogen and
progesterone receptor immunoreactivity in human breast cancer. J
Microsc. 226:244–255. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yamamoto-Ibusuki M, Yamamoto Y, Yamamoto
S, Fujiwara S, Fu P, Honda Y, Iyama K and Iwase H: Comparison of
prognostic values between combined immunohistochemical score of
estrogen receptor, progesterone receptor, human epidermal growth
factor receptor 2, Ki-67 and the corresponding gene expression
score in breast cancer. Mod Pathol. 26:79–86. 2013. View Article : Google Scholar
|
|
40
|
Monroe GR, Harakalova M, van der Crabben
SN, Majoor-Krakauer D, Bertoli-Avella AM, Moll FL, Oranen BI,
Dooijes D, Vink A, Knoers NV, et al: Familial Ehlers-Danlos
syndrome with lethal arterial events caused by a mutation in
COL5A1. Am J Med Genet A. 167:1196–1203. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Fang M, Adams JS, McMahan BL, Brown RJ and
Oxford JT: The expression patterns of minor fibrillar collagens
during development in zebrafish. Gene Expr Patterns. 10:315–322.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sun M, Connizzo BK, Adams SM, Freedman BR,
Wenstrup RJ, Soslowsky LJ and Birk DE: Targeted deletion of
collagen V in tendons and ligaments results in a classic
Ehlers-Danlos syndrome joint phenotype. Am J Pathol. 185:1436–1447.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sun M, Chen S, Adams SM, Florer JB, Liu H,
Kao WW, Wenstrup RJ and Birk DE: Collagen V is a dominant regulator
of collagen fibrillogenesis: Dysfunctional regulation of structure
and function in a corneal-stroma-specific Col5a1-null mouse model.
J Cell Sci. 124:4096–4105. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Luparello C, Sheterline P, Pucci-Minafra I
and Minafra S: A comparison of spreading and motility behaviour of
8701-BC breast carcinoma cells on type I, I-trimer and type V
collagen substrata. Evidence for a permissive effect of type
I-trimer collagen on cell locomotion. J Cell Sci. 100:179–185.
1991.PubMed/NCBI
|
|
45
|
Rubiś P, Wiśniowska-Smiałek S, Wypasek E,
Rudnicka-Sosin L, Hlawaty M, Leśniak-Sobelga A, Kostkiewicz M and
Podolec P: 12-month patterns of serum markers of collagen
synthesis, transforming growth factor and connective tissue growth
factor are similar in new-onset and chronic dilated cardiomyopathy
in patients both with and without cardiac fibrosis. Cytokine.
96:217–227. 2017. View Article : Google Scholar
|
|
46
|
Margetts PJ, Bonniaud P, Liu L, Hoff CM,
Holmes CJ, West-Mays JA and Kelly MM: Transient overexpression of
TGF-{beta}1 induces epithelial mesenchymal transition in the rodent
peritoneum. J Am Soc Nephrol. 16:425–436. 2005. View Article : Google Scholar
|
